Bluejay Diagnostics Announces Reverse Stock Split

Bluejay Diagnostics, Inc. (NASDAQ:BJDX) has announced a 1-for-4 reverse stock split, approved by the Company's Board. This will take effect on November 3, 2026. Trading on The Nasdaq Capital Market will continue under the same symbol, "BJDX", but with a new CUSIP number, 095633707.

After the split, every four shares of common stock will consolidate into one, reducing the outstanding shares from approximately 4.5 million to 1.1 million. Fractional shares will not be issued; instead, shareholders will receive cash payments. This move impacts all stockholders proportionally, with no change to any individual stake percentage.

Continental Stock Transfer & Trust Company will manage the reverse stock split exchange process. Certificate holders will receive instructions, while book-entry and brokerage account holders need not take action.